May 10, 2022 – Congratulations to our Agility Labs member, CytoTronics, on closing $9.25 Million in seed funding

Congratulations to our Agility Labs member, CytoTronics, on closing $9.25 Million in seed funding, led by Anzu Partners with participation from Milad Alucozai (BoxOne Ventures) and institutional investors, to revolutionize drug discovery and phenotypic screening. Triple Ring is proud to be a part of the journey to provide the facility, technology, and mentorship support to CytoTronics from the very beginning. If you are interested in learning about CytoTronics and its complementary metal-oxide-semiconductor (CMOS)-powered drug discovery platform, please visit https://cytotronics.com/. If you are looking for a lab space to launch your innovative business, Agility Labs offers a flexible incubator for emerging life sciences, medical device, and technology companies in Silicon Valley and Boston. For more information, please visit our website at https://www.agilitylabs.org/ or email your inquiries to info@tripleringtech.com.